Background: Cardiovascular disease is the leading cause of death both globally and nationally. Type II diabetes poses a major risk factor in the development of cardiovascular disease. New guidelines for cardiovascular disease prevention aim to calculate patients’ ASCVD 10-year risk and treat with statin medication based on risk. EBP Framework: The Iowa Model Revised and Kurt Lewin’s change theory provided the framework for this scholarly project. These models guided the development, implementation, and evaluation of the scholarly project’s design. Methods: This scholarly project aimed to determine if practice change involving education intervention and an emphasis on calculating patient ASCVD 10-year risk would increase the number fo diabetic patients on appropriate cholesterol lowering therapy. After IRB approval, the project manager used a retrospective chart review to evaluate outcomes and gather data. Findings/Results: This proejct measured the number of patients statin use, those screening for ASCVD risk, and if a patient was on an appropriate intensity statin pre- and post-intervention. The project results indicated that the practice change increased the number of patients screening for ASCVD risk but did not increase the number of patients on statin therapy or appropriate statin intensity. All patients who declined statin use in this project cited effects as the primary reason. Conclusion/Recommendations: Incorporating a practice change into practice increased the number of patients screened for ASCVD risk but did not increase statin use or the number of patients on appropriate statin therapy. It can be concluded that this practice change is beneficial in increasing patients screened for ASCVD risk but that additional change is required to increase statin use in this population.
